Zymeworks Inc. - Common Stock (NQ:ZYME)

24.02 +0.20 (+0.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Price and Volume

Volume	1,688,378
Open	23.82
Bid (Size)	23.70 (200)
Ask (Size)	24.61 (200)
Prev. Close	23.82
Today's Range	23.77 - 25.00
52wk Range	9.030 - 26.19
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:NTLA),(NASDAQ:ZYME),(NYSE:ANVS) EQNX::TICKER_END

Via FinancialNewsMedia

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

From MarketNewsUpdates.com

Via GlobeNewswire

Performance

YTD	+62.5%	+62.5%
1 Month	+35.9%	+35.9%
3 Month	+59.1%	+59.1%
6 Month	+108.1%	+108.1%
1 Year	+75.6%	+75.6%

More News

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

5 Analysts Have This To Say About Zymeworks ↗

October 24, 2025

Via Benzinga

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 18, 2025

Via Benzinga

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

November 18, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

November 18, 2025

From Zymeworks Inc.

Via GlobeNewswire

Let's take a look at the stocks that are in motion in today's session. ↗

November 17, 2025

Via Chartmill

Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans ↗

November 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 17, 2025

Via Benzinga

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

The market is filled with gapping stocks in Monday's session. ↗

November 17, 2025

Via Chartmill

Mixed Signals Point to Cautious Open for U.S. Markets as Tech Shines Amidst Economic Data Delays

November 17, 2025

Via MarketMinute

Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer ↗

November 17, 2025

Via Investor's Business Daily

These stocks are moving in today's pre-market session ↗

November 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 17, 2025

Via Benzinga

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

November 17, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Inc (NASDAQ:ZYME) Shows Strong Technical and Fundamental Momentum ↗

November 11, 2025

Via Chartmill

Zymeworks Inc (NASDAQ:ZYME) Reports Mixed Q3 2025 Results with Narrower Loss but Revenue Miss ↗

November 06, 2025

Via Chartmill

Zymeworks Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 06, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

October 28, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

October 23, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

October 16, 2025

From Zymeworks Inc.

Via GlobeNewswire

Broadcom To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 14, 2025

Via Benzinga

This RPM International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

October 14, 2025

Via Benzinga

Frequently Asked Questions

Is Zymeworks Inc. - Common Stock publicly traded?

Yes, Zymeworks Inc. - Common Stock is publicly traded.

What exchange does Zymeworks Inc. - Common Stock trade on?

Zymeworks Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Zymeworks Inc. - Common Stock?

The ticker symbol for Zymeworks Inc. - Common Stock is ZYME on the Nasdaq Stock Market

What is the current price of Zymeworks Inc. - Common Stock?

The current price of Zymeworks Inc. - Common Stock is 24.02

When was Zymeworks Inc. - Common Stock last traded?

The last trade of Zymeworks Inc. - Common Stock was at 11/21/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.